Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 1;15(1):15309.
doi: 10.1038/s41598-025-98991-0.

Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus

Affiliations

Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus

Vikram R Shaw et al. Sci Rep. .

Abstract

Inflammatory bowel disease (IBD) is an autoimmune disease (AD) characterized by chronic, relapsing intestinal inflammation. Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multisystem involvement and overactivation of both innate and adaptive immunity. The extra intestinal manifestations (EIMs) that commonly occur in IBD include many of the organ sites that are affected by SLE. ADs are often comorbid with one another and may have shared underlying genetic features and architectures contributing to their pathogenesis and disease course. We performed both epidemiological and post-genome wide association study (GWAS) analyses to investigate the shared genetic features between IBD and systemic lupus erythematosus (SLE). Specifically, we performed epidemiological association analysis in the All of Us Research Program (AoURP) and genome-wide/local genetic correlation analysis and cell-type specific SNP heritability enrichment analysis using previously published summary level data. A significant epidemiologic association exists between IBD and SLE with an adjusted odds ratio (aOR) of 2.94 (95% CI: 2.45-3.53; P < 0.001) in a multivariable model accounting for confounders in the AoURP data. Genome-wide genetic correlation analysis in previously published summary level data demonstrated a significant genetic correlation between IBD, CD, and UC with SLE, and local genetic correlation analysis demonstrated several positive and significant correlations in local genomic regions harboring disease variants in genes common to both SLE and IBD etiology, including variants in ELF1, CD226, JAZF1, WDFY4, and JAK2. Cell-type SNP heritability enrichment analysis identified both overlapping and distinct functional categories contributing to SNP heritability across IBD phenotypes. Notably, IBD-related phenotypes demonstrated significant enrichment in T-lymphocyte functional groups while SLE signal appeared in distinct categories, such as B-lymphocytes (along with CD). Gene-level collapsing analysis of rare variants in the United Kingdom BioBank (UKBB) identified overlapping nominally-significant genes between SLE and IBD, CD, and UC. By leveraging several post-GWAS methods, the present study identifies shared genetic features between IBD and SLE, highlighting similarities and differences in the genetic features that contribute to the pathogenesis of each disease.

Keywords: Autoimmune disease; Inflammatory bowel disease; Systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: Jeffrey M. Cohen (JMC) serves on a data and safety monitoring board for Advarra and has served as a consultant for Novartis and Takeda. The other authors have no competing interests to declare.

Figures

Fig. 1
Fig. 1
Local genetic correlation analysis for CD-SLE (A) and UC-SLE (B). Top panel: Nominally significant (P < 0.05) positive correlations are shown as circles while correlations achieving Bonferroni-corrected significance are indicated with triangles. Notable genomic regions harboring shared disease-specific variants are indicated with arrows and labels. Functional annotation analysis for CD-SLE (C) and UC-SLE (D). Bottom panel: Functional annotation of each highlighted genomic region using FAVOR functional annotation platform.
Fig. 2
Fig. 2
sLDSC cell-type specific partitioned heritability analysis for IBD, CD, UC, and SLE across several immune cells of interest. Red dashed line indicates P-value cutoff for 5% FDR-adjusted significance.

Update of

Similar articles

References

    1. Baumgart, D. C. & Sandborn, W. J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet369 (9573), 1641–1657. 10.1016/S0140-6736(07)60751-X (2007). - PubMed
    1. Ananthakrishnan, A. N. et al. Environmental triggers in IBD: a review of progress and evidence. Nat. Rev. Gastroenterol. Hepatol.15 (1), 39–49. 10.1038/nrgastro.2017.136 (2018). - PubMed
    1. Yang, Y. et al. Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases. Nat. Commun.12 (1), 5641. 10.1038/s41467-021-25768-0 (2021). - PMC - PubMed
    1. Attalla, M. G., Singh, S. B., Khalid, R., Umair, M. & Epenge, E. Relationship between ulcerative colitis and rheumatoid arthritis: A review. Cureus11 (9), e5695. 10.7759/cureus.5695 (2019). - PMC - PubMed
    1. Fang, Y. et al. Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: opportunities and challenges. Autoimmun. Rev.22 (3), 103260. 10.1016/j.autrev.2022.103260 (2023). - PubMed

MeSH terms